Effects of captopril, diuretic, and their combination in low-renin essential hypertension
- 31 December 1980
- journal article
- clinical trial
- Published by Elsevier in Life Sciences
- Vol. 27 (25-26), 2519-2522
- https://doi.org/10.1016/0024-3205(80)90532-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.Hypertension, 1979
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Spironolactone and hydrochlorothiazide in normal‐renin and low‐renin essential hypertensionClinical Pharmacology & Therapeutics, 1977
- Aldosterone Metabolic Clearance is Normal in Low-Renin Essential HypertensionJournal of Clinical Endocrinology & Metabolism, 1976
- BODY-FLUID VOLUME IN LOW-RENIN HYPERTENSIONThe Lancet, 1974
- Volume factor in low and normal renin essential hypertension: Treatment with either spironolactone or chlorthalidoneThe American Journal of Cardiology, 1973
- The control of aldosterone secretion in normal and hypertensive man: Abnormal renin-aldosterone patterns in low renin hypertensionThe American Journal of Medicine, 1972
- A Radioimmunoassay for Aldosterone in Human Peripheral Plasma Including a Comparison of Alternate TechniquesJournal of Clinical Endocrinology & Metabolism, 1972
- Incidence of Suppressed Renin Activity and of Normokalemic Primary Aldosteronism in Hypertensive Negro PatientsCirculation, 1968